Non-lipid-related effects of statins (Q33924588)

30 July 2017

1 reference

title

Non-lipid-related effects of statins (English)

1 reference

30 July 2017

Bellosta S

1 reference

30 July 2017

Ferri N

1 reference

30 July 2017

Bernini F

1 reference

30 July 2017

Paoletti R

1 reference

30 July 2017

Corsini A

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

164-176

1 reference

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Regulation of the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Prenyl proteins in eukaryotic cells: a new type of membrane anchor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Update on the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Antioxidants and Atherosclerotic Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

The L-arginine-nitric oxide pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Fluvastatin reduces endothelin secretion of cultured human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Mevalonate availability and cardiovascular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Mevalonate availability affects human and rat resistance vessel function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Farnesyl analogues inhibit vasoconstriction in animal and human arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

PECAM-1 is required for transendothelial migration of leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Control of plasma fibrinogen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Effect of lovastatin on intimal hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Coronary Plaque Disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Loss of feedback control of hydroxymethylglutaryl coenzyme A reductase in hepatomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

In vitro and in vivo antiproliferative effects of simvastatin, an HMG-CoA reductase inhibitor, on human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Stimulation of bone formation in vitro and in rodents by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

Simvastatin releases Ca2+ from a thapsigargin-sensitive pool and inhibits InsP3-dependent Ca2+ mobilization in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890008998823

10.3109/07853890008998823

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference